Driving Night Blindness Treatment Market Growth in 2025: The Role of Impact Of Increasing Cataract Prevalence On The Night Blindness Treatment Market

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Night Blindness Treatment Market Size Growth Forecast: What to Expect by 2025?
The market for treating night blindness has seen significant expansion in the recent past. There is an expected increase from $3.95 billion in 2024 to $4.21 billion in 2025, indicating a compound annual growth rate (CAGR) of 6.7%. This notable increase during the historic period can be attributed to the increasing incidences of vitamin A deficiency, a surge in the elderly population susceptible to night vision issues, the widening of healthcare infrastructure, a heightened focus on nutritional interventions for vision health, and an escalating occurrence of retinitis pigmentosa.

How Will the Night Blindness Treatment Market Size Evolve and Grow by 2029?
In the ensuing years, a robust expansion is anticipated for the market of night blindness treatment, with an expected rise to $5.39 billion in 2029 at a compound annual growth rate (CAGR) of 6.3%. The amplification during this forecast period can be credited to factors like the ever-increasing embracement of superior diagnostic tech, proliferating campaigns about eye health, escalating demand for bespoke medicine, and the expansion of eye care clinics and infrastructure in the healthcare sector. The forecast period is likely to witness major trends including the utilization of innovative diagnostic technological advancements, personalized treatment implementation, the advent of gene therapy and stem cell treatments, the use of wearable technology for instantaneous monitoring, and the growth of multi-disciplinary clinics.

View the full report here:
https://www.thebusinessresearchcompany.com/report/night-blindness-treatment-global-market-report

What Drivers Are Propelling the Growth of Night Blindness Treatment Market Forward?
The elevation in cataract incidents is predicted to fuel the expansion of the night blindness treatment market. Cataracts are a condition characterised by a clouding of the eye's lens, leading to compromised vision. Exposure to the sun's ultraviolet (UV) rays, smoking habits, and a substandard diet are factors that contribute to the formation of cataracts. Notably, cataracts hamper the eye's ability to differentiate various light and dark hues, which is vital for night vision. This diminished contrast sensitivity complicates navigating and object identification in dimly lit conditions. In a reference event, the 2021-23 National UK Eye Care Statistics Survey carried out by the Well-being of Future Generations Act (WFG), a governmental agency based in the UK, reported an estimated 16,500 (or 16,510 to be precise) cataract cases in 2022-23 in July 2023, a spike of 23.7% compared to the prior year. Hence, the growing incidence of cataracts acts as a catalyst for the growth of the night blindness treatment market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18413&type=smp

Which Emerging Trends Are Transforming the Night Blindness Treatment Market in 2025?
Leading corporations in the night blindness treatment market are revolutionizing genetic therapies, aiming to enhance treatment effectiveness by addressing the root genetic mutations that cause night blindness. These innovative therapies repair particular genetic mutations that compromise retinal functionality, potentially offering vision restoration to those suffering from inherited retinal conditions such as retinitis pigmentosa. For example, in August 2023, HuidaGene Therapeutics, a pioneering biotech company in the U.S., launched HG004. This gene therapy aims to treat inherited retinal disorders like Leber's congenital amaurosis. It has proven superior to current treatments in early studies, with goals to repair retinal functionality and relieve symptoms of night blindness and other retina-related impairments linked to RPE65.

What Are the Key Segments in the Night Blindness Treatment Market?
The night blindness treatment market covered in this report is segmented -

1) By Treatment: Medication, Surgery, Other Treatments
2) By Diagnosis: Blood Tests, Color Vision Testing, Pupil Light Reflex, Refraction, Retinal Exam, Electroretinogram (ERG), Other Diagnoses
3) By Symptom: Eye Pain, Vomiting, Cloudy Vision, Halos, Light Sensitivity, Distance Vision Problem, Headache, Other Symptoms
4) By End User: Clinic, Hospital, Other End Users

Subsegments:
1) By Medication: Vitamin A Supplements, Retinoid Therapy, Beta-Carotene Supplements, Anti-Glaucoma Medications, Other Pharmaceutical Treatments
2) By Surgery: Cataract Surgery, Retinal Surgery, Corneal Transplantation, LASIK Surgery
3) By Other Treatments: Light Therapy, Gene Therapy, Low Vision Aids And Assistive Devices, Nutritional Therapy

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=18413&type=smp

Who Are the Key Players Shaping the Night Blindness Treatment Market's Competitive Landscape?
Major companies operating in the night blindness treatment market are Johnson & Johnson Private Limited, F. Hoffmann-La Roche Ltd., Bayer AG, Abbott Laboratories, Novartis AG, Boehringer Ingelheim, Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Biogen Inc., Bausch Health Companies Inc., Eisai Co. Ltd, Cipla Inc., Nature's Way, Spark Therapeutics Inc., Garden of Life, Apellis Pharmaceuticals Inc, Solgar, Acucela Inc., Swanson Health Products, NOW Foods

What Geographic Markets Are Powering Growth in the Night Blindness Treatment Market?
North America was the largest region in the night blindness treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the night blindness treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18413

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.